299 related articles for article (PubMed ID: 18713766)
1. Activation of mouse and human peroxisome proliferator-activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths.
Wolf CJ; Takacs ML; Schmid JE; Lau C; Abbott BD
Toxicol Sci; 2008 Nov; 106(1):162-71. PubMed ID: 18713766
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.
Wolf CJ; Rider CV; Lau C; Abbott BD
Toxicology; 2014 Feb; 316():43-54. PubMed ID: 24374136
[TBL] [Abstract][Full Text] [Related]
3. Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds.
Wolf CJ; Schmid JE; Lau C; Abbott BD
Reprod Toxicol; 2012 Jul; 33(4):546-551. PubMed ID: 22107727
[TBL] [Abstract][Full Text] [Related]
4. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
Takacs ML; Abbott BD
Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
[TBL] [Abstract][Full Text] [Related]
5. Transactivation potencies of the Baikal seal (Pusa sibirica) peroxisome proliferator-activated receptor α by perfluoroalkyl carboxylates and sulfonates: estimation of PFOA induction equivalency factors.
Ishibashi H; Kim EY; Iwata H
Environ Sci Technol; 2011 Apr; 45(7):3123-30. PubMed ID: 21381677
[TBL] [Abstract][Full Text] [Related]
6. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of perfluoroalkyl acid activity using primary mouse and human hepatocytes.
Rosen MB; Das KP; Wood CR; Wolf CJ; Abbott BD; Lau C
Toxicology; 2013 Jun; 308():129-37. PubMed ID: 23567314
[TBL] [Abstract][Full Text] [Related]
8. Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells.
Rosenmai AK; Ahrens L; le Godec T; Lundqvist J; Oskarsson A
J Appl Toxicol; 2018 Feb; 38(2):219-226. PubMed ID: 28857218
[TBL] [Abstract][Full Text] [Related]
9. trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals.
Maloney EK; Waxman DJ
Toxicol Appl Pharmacol; 1999 Dec; 161(2):209-18. PubMed ID: 10581215
[TBL] [Abstract][Full Text] [Related]
10. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures.
Bjork JA; Wallace KB
Toxicol Sci; 2009 Sep; 111(1):89-99. PubMed ID: 19407336
[TBL] [Abstract][Full Text] [Related]
12. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
Bility MT; Thompson JT; McKee RH; David RM; Butala JH; Vanden Heuvel JP; Peters JM
Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
[TBL] [Abstract][Full Text] [Related]
13. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
[TBL] [Abstract][Full Text] [Related]
14. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.
Shipley JM; Hurst CH; Tanaka SS; DeRoos FL; Butenhoff JL; Seacat AM; Waxman DJ
Toxicol Sci; 2004 Jul; 80(1):151-60. PubMed ID: 15071170
[TBL] [Abstract][Full Text] [Related]
15. Contamination and effects of perfluorochemicals in Baikal seal (Pusa sibirica). 2. Molecular characterization, expression level, and transcriptional activation of peroxisome proliferator-activated receptor alpha.
Ishibashi H; Iwata H; Kim EY; Tao L; Kannan K; Tanabe S; Batoev VB; Petrov EA
Environ Sci Technol; 2008 Apr; 42(7):2302-8. PubMed ID: 18504957
[TBL] [Abstract][Full Text] [Related]
16. Regulation of peroxisome proliferator-activated receptor alpha by protein kinase C.
Gray JP; Burns KA; Leas TL; Perdew GH; Vanden Heuvel JP
Biochemistry; 2005 Aug; 44(30):10313-21. PubMed ID: 16042408
[TBL] [Abstract][Full Text] [Related]
17. Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha) via a PPRE located in the first intron.
Wen G; Ringseis R; Eder K
Biochem Pharmacol; 2010 Mar; 79(5):768-76. PubMed ID: 19819229
[TBL] [Abstract][Full Text] [Related]
18. Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.
Rosen MB; Abbott BD; Wolf DC; Corton JC; Wood CR; Schmid JE; Das KP; Zehr RD; Blair ET; Lau C
Toxicol Pathol; 2008 Jun; 36(4):592-607. PubMed ID: 18467677
[TBL] [Abstract][Full Text] [Related]
19. Testing for departures from additivity in mixtures of perfluoroalkyl acids (PFAAs).
Carr CK; Watkins AM; Wolf CJ; Abbott BD; Lau C; Gennings C
Toxicology; 2013 Apr; 306():169-75. PubMed ID: 23470359
[TBL] [Abstract][Full Text] [Related]
20. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha.
Gray JP; Davis JW; Gopinathan L; Leas TL; Nugent CA; Vanden Heuvel JP
Toxicol Sci; 2006 Feb; 89(2):535-46. PubMed ID: 16280383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
